MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Evoke Pharma DPO Ratio 2011-2026 | EVOK
Annual DPO Ratio Evoke Pharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 5.36 K | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.36 K | 5.36 K | 5.36 K |
DPO Ratio of other stocks in the Drug manufacturers industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
38 | - | 7.5 % | $ 6.35 M |  USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
345 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
116 | - | - | $ 754 M | USA |
 |
Assertio Holdings
ASRT
|
122 | $ 19.21 | -3.37 % | $ 123 M | USA |
 |
Canopy Growth Corporation
CGC
|
52.8 | $ 1.0 | 2.63 % | $ 108 M |  Canada |
 |
Avadel Pharmaceuticals plc
AVDL
|
224 | - | - | $ 2.06 B |  France |
 |
Cronos Group
CRON
|
212 | $ 2.53 | 0.8 % | $ 1.33 B | Canada |
 |
Aurora Cannabis
ACB
|
-807 | $ 3.44 | 2.69 % | $ 86.3 M | Canada |
 |
Catalent
CTLT
|
41.8 | - | - | $ 11.5 B | USA |
 |
Agile Therapeutics
AGRX
|
352 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
309 | - | - | $ 142 M | USA |
 |
China Pharma Holdings
CPHI
|
47.6 | $ 0.63 | -1.56 % | $ 2.7 M |  China |
 |
Athenex
ATNX
|
111 | - | -23.39 % | $ 1.76 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
75.6 | - | -39.89 % | $ 27.7 M | USA |
 |
DURECT Corporation
DRRX
|
519 | - | - | $ 50.1 M | USA |
 |
Emergent BioSolutions
EBS
|
55.8 | $ 8.23 | -1.79 % | $ 421 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
775 | $ 3.17 | 2.26 % | $ 44.6 M | USA |
 |
Endo International plc
ENDP
|
39.3 | - | - | $ 28.9 M |  Irlanda |
 |
Bausch Health Companies
BHC
|
78.1 | $ 5.35 | -4.12 % | $ 1.95 B | Canada |
 |
Harrow Health
HROW
|
199 | $ 35.31 | -0.34 % | $ 1.3 B | USA |
 |
Jupiter Wellness
JUPW
|
318 | - | - | $ 33.6 M | USA |
 |
Evolus
EOLS
|
59.4 | $ 4.03 | -6.5 % | $ 260 M | USA |
 |
Lannett Company
LCI
|
36.8 | - | 1.15 % | $ 7.11 M | USA |
 |
OptiNose
OPTN
|
194 | - | - | $ 1.08 B | USA |
 |
Organogenesis Holdings
ORGO
|
94 | $ 2.24 | -3.03 % | $ 295 M | USA |
 |
Pacira BioSciences
PCRX
|
37.3 | $ 22.7 | -0.39 % | $ 1.05 B | USA |
 |
PetIQ
PETQ
|
54.2 | - | 1.64 % | $ 400 M | USA |
 |
Perrigo Company plc
PRGO
|
64.2 | $ 10.85 | -1.36 % | $ 1.5 B | USA |
 |
ProPhase Labs
PRPH
|
45.4 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
274 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
6.63 | - | -4.76 % | $ 65.3 M | USA |
 |
Rockwell Medical
RMTI
|
15.4 | $ 0.96 | 2.54 % | $ 34.5 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
32.3 | $ 2.37 | -2.47 % | $ 2.94 M | USA |
 |
Viatris
VTRS
|
64 | $ 13.44 | -1.39 % | $ 16.1 B | USA |
 |
cbdMD
YCBD
|
84 | $ 0.73 | 2.37 % | $ 3.15 M | USA |
 |
Zomedica Corp.
ZOM
|
64.3 | - | -0.21 % | $ 98 M | USA |
 |
SCYNEXIS
SCYX
|
20.2 | $ 0.89 | -0.05 % | $ 44.4 M | USA |
 |
TherapeuticsMD
TXMD
|
723 | $ 2.0 | - | $ 23.1 M | USA |
 |
Tilray
TLRY
|
53 | $ 6.55 | 6.68 % | $ 4.05 B | Canada |